Ireland is currently almost alone among western European countries in not granting patients access to modern cell and gene therapy treatments, it says. Money is a major drawback, the Pathfinder Study on the Adoption of Cell and Gene Therapies in Ireland acknowledges. Gene therapy replaces faulty DNA to cure genetic diseases. It recognises that current reimbursement models will not work for cell and gene therapies. We need to explore how we can deliver both clinical benefit and value for money from cell and gene therapy adoption,”“Cell and gene therapies are revolutionising medicine,” said Prof David Keegan, a consultant at the Mater hospital in Dublin, and a specialist in ophthalmology.

Source: The Irish Times May 27, 2021 04:07 UTC